Pooja Umesh Shenoy1
Hrushikesh Udupa2
A. I. Ananthakrishnan1Punya Sunil1Urvinder Kaur Sardarni3
Narendra Kumar3
Arpan Acharya3
Siddappa N. Byrareddy3*
Priyanka Upadhyai4*
Ranajit Das1*- 1Division of Data Analytics, Bioinformatics and Structural Biology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India
- 2Department of Community Medicine, Yenepoya (Deemed to be University), Mangalore, Karnataka, India
- 3Department of Pharmacology and Experimental Neuroscience, Durham Research Center 8052, 985800 Nebraska Medical Center, Omaha, NE, United States
- 4Department of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
Background: Susceptibility to infectious diseases is a result of complex interactions between genomic, environmental, and clinical factors. COVID-19 severity and post-acute sequelae of COVID-19 (PASC) vary widely among individuals, yet its genetic determinants remain underexplored in Indian populations. In this article, we undertake an exploratory analysis to investigate candidate genetic variants and biological pathways underlying the clinical outcomes in COVID-19 severity and PASC.
Methods: Sixty individuals with a history of COVID-19 were genotyped, and their data were supplemented with publicly available datasets from the Genome Asia 100K and Gujarat Biotechnology Research Centre. Two case–control genome-wide association study (GWAS) models were analyzed: (i) COVID-19 severity (mild/asymptomatic vs. severe) and (ii) an exploratory, hypothesis-generating GWAS for PASC (presence vs. absence of post-COVID-19 complications). Candidate genes identified here were further compared with RNA-sequencing datasets derived from brain and lung tissues of SARS-CoV-2-infected hamsters. The population-specific genetic risk for PASC was estimated using the polygenic risk score algorithm PRSice-2.
Results: GWAS identified candidate genes common to both COVID-19 severity and PASC, including CNTNAP2, WWOX, and ADAMTS17, which are implicated in extracellular matrix remodeling and neurological and cognitive development. We identified 806 candidate genes shared between the severity and PASC cohorts. Of these, 30 protein-coding genes were associated with neuropsychiatric disorders, and 23 were linked to cardiovascular conditions. Notably, CACNA1C, SLC8A1, GRK5, PDE4B, and LRRK2 were identified in both categories, suggesting potential convergence of molecular pathways underlying neurological and cardiovascular dysfunction. Integration with transcriptomic data reinforced the involvement of shared molecular pathways disrupted by SARS-CoV-2 infection. Polygenic risk analysis revealed significant population-specific variation in genetic predisposition to PASC.
Conclusion: Genetic susceptibility to severe COVID-19 and PASC in Indian populations appears to be linked to dysregulation of pathways central to cardiac and neurological function. These findings, derived from an exploratory PASC GWAS, provide preliminary insights into the molecular mechanisms that may underlie the post-viral sequelae. These emphasize the need for population-wide genomic studies to validate the candidate associations, better understand PASC risk, and facilitate the development of precision diagnostics and therapeutics.
GRAPHICAL ABSTRACT |
Introduction
During infection, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses intricate mechanisms to exploit host-cell processes and evade antiviral defenses (Steiner et al., 2024), leading to a broad spectrum of manifestations ranging from asymptomatic to severe clinical outcomes (Gandhi et al., 2020; Rothan and Byrareddy, 2020). A series of genome- and exome-wide association studies using population-based or asymptomatic/mildly affected individuals as controls pointed to the heterogeneity of host genetic makeup as an important modulator of the clinical variability and severity of coronavirus disease 19 (COVID-19) infections (Ellinghaus et al., 2020; Li et al., 2021; Mousa et al., 2021; Niemi et al., 2021; Pairo-Castineira et al., 2021; Shelton et al., 2021; Upadhyai et al., 2021; Kousathanas et al., 2022; Upadhyai et al., 2022). The latest release and meta-analysis work by the Host Genetics Initiative, investigating both European and non-Caucasian ancestries across 35 countries, inferred single-nucleotide variants (SNVs) in several genes, including those previously reported to be linked with SARS-CoV-2 infection, critical illness, and hospitalization—for example, solute carrier family 6 member 20 (SLC6A20), alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase (ABO), surfactant protein D (SFTPD), and transmembrane serine protease 2 (TMPRSS2) (viral entry); mucin 1 (MUC1) and mucin 5B (MUC5B) (respiratory mucosal defense); interferon alpha and beta receptor 2 (IFNAR2) subunit, 2'-5'-oligoadenylate synthetase 1 (OAS1), and tyrosine kinase 2 (TYK2) (type I interferon pathway); and forkhead box P4 (FOXP4), SFTPD, and dipeptidyl peptidase 9 (DPP9) (lung homeostasis) (Kanai et al., 2023). Novel loci, such as mucin 4 (MUC4), mucin 16 (MUC16), Janus kinase 1 (JAK1), interferon regulatory factor 1 (IRF1), interferon alpha 10 (IFNA10), calcium and integrin binding family member 4 (CIB4), nephronectin (NPNT), zinc finger with KRAB and SCAN domains 1 (ZKSCAN1), ATPase phospholipid transporting 11A (ATP11A), and proteasome 26S subunit, non-ATPase 3 (PSMD3), were also associated with variable COVID-19 morbidity.
Increasing evidence has revealed long-term clinical complications and multisystemic sequelae among COVID-19 patients who “recovered” from acute illness, termed as post-acute sequelae of COVID-19 (PASC) or “long COVID.” The World Health Organization (WHO) defines PASC as new or recurring health complications in individuals with probable or confirmed SARS-CoV-2 infection, usually 3 months after the onset of COVID-19, with symptoms that last at least for 2 months and cannot be explained by an alternative diagnosis (Author Anonymous, 2022). Estimates suggest that at least 65 million people could be affected by PASC worldwide (Ballering et al., 2022; Davis et al., 2023), with its prevalence likely ranging from 27% to 35% in the US (Statistics, 2022; Khan and Becker, 2024). The incidence of PASC was estimated at 10%–30%, 50%–70%, and 10%–12% among non-hospitalized, hospitalized, and vaccinated individuals, respectively (Al-Aly et al., 2022; Ayoubkhani et al., 2022; Ceban et al., 2022). A 3-year follow-up study showed that hospitalized patients faced a substantially higher risk of mortality and health loss (Cai et al., 2024).
PASC can involve mild to severe health complications affecting the cardiovascular, thrombotic, cerebrovascular, neurological, pulmonary, and endocrine systems and can manifest with over 200 different symptoms, including fatigue, dyspnea, and pulmonary dysfunction (Author Anonymous, 2022; Davis et al., 2023). Even patients without a history of comorbidities are highly liable to develop PASC, such as myocardial derangements (Dehghan et al., 2024) and new-onset type 2 diabetes in adults (Harding et al., 2023) and children (Miller et al., 2024). A UK-based epidemiological study noted that 7.2% of young individuals (11–17 years) showed a median of 5–6 symptoms of PASC at 3-, 6-, 12-, and 24-months post-infection, with repeated SARS-CoV-2 infection exacerbating its severity (Stephenson et al., 2024). New-onset neurocognitive and mood disorders, along with other neurological symptoms, including brain fog, headache, sensory dysregulation, balance issues, hearing loss, autonomic dysfunction, and stroke, have also been reported among individuals with PASC (Crivelli et al., 2022; Spudich and Nath, 2022).
Neuroimaging studies report that PASC can involve structural and functional brain abnormalities, such as a reduction in gray matter and brain volume (Douaud et al., 2022), decreased neurovascular perfusion in patients with chronic cognitive deficiencies (Ajčević et al., 2023), immune dysregulation in the cerebrospinal fluid (Mina et al., 2023), and a significant increase in neuroinflammation in many regions of the brain (VanElzakker et al., 2024). In some studies, the risk of cognitive derangements was found to be comparable among hospitalized and non-hospitalized COVID-19 patients (Woo et al., 2020).
The risk and severity of PASC can vary with age and the acuteness of viral infection (Huang et al., 2021; Han et al., 2022), yet cases also occur among asymptomatic or mildly affected COVID-19 patients (Malkova et al., 2021). Contributing factors for this include gender differences and preexisting comorbidities, such as obesity, diabetes, smoking, and socioeconomic status (Subramanian et al., 2022; Yu et al., 2024). Genetic predisposition to COVID-19 may further modulate susceptibility to PASC-related health complications, such as fatigue, headache, pneumonia and airway infections, and heart failure (Shenoy et al., 2023), but this remains largely unexplored outside European populations.
The Indian subcontinent is a region of remarkable diversity; its genetic makeup has been shaped by multiple waves of archaic gene flow (Reich et al., 2009; Basu et al., 2016; Narasimhan et al., 2019; Kumar et al., 2023; Kerdoncuff et al., 2024), along with stringent socioeconomic and cultural practices that have created over 5,000 anthropologically well-defined and largely endogamous populations, including >700 recognized as scheduled tribes (Mastana, 2014). It offers a unique opportunity to investigate population-specific genetic determinants of infectious disease response. Previous Indian studies have focused mainly on the evolution of the SARS-CoV-2 variants during successive waves of the COVID-19 pandemic (Misra et al., 2023; Ravi et al., 2023; Jena et al., 2024; Selvavinayagam et al., 2024; Wadhwa et al., 2024), with few reporting host–genetic associations related to COVID-19 severity—e.g., rs1981458 in furin, paired basic amino acid cleaving enzyme (FURIN) (Pandey et al., 2024) and rs479200 in Egl-9 family hypoxia inducible factor 1 (EGLN1) (Harit et al., 2024); non-synonymous SNVs in angiotensin converting enzyme 2 (ACE2) that encodes for the receptor of the SARS-CoV-2 spike protein were predicted to alter individual susceptibility to SARS-CoV-2 omicron subvariants (Samanta et al., 2023).
The incidence and clinical spectrum of PASC in India remain poorly defined. One study suggested that elevated and persistent D-dimer levels may be associated with a high risk for PASC (Kalaivani and Dinakar, 2022). A retrospective observational study in the western Indian state of Maharashtra reported ∼6.48% of PASC cases, with ∼1.94% of patients developing new conditions, such as lung fibrosis, asthma, and hypertension (Karyakarte et al., 2023). Another work indicated that ∼64% of individuals experienced PASC symptoms with higher body mass index (BMI), obesity, hypertension, and abnormal chest X-ray as risk factors (Thyagaraj et al., 2022). A population-based study examined PASC symptoms over 6 months in the northern Indian state of Haryana and reported a significant persistence of cough among individuals with PASC, with higher risk observed in women (Chaudhry et al., 2024). However, none of these have assessed host genetic variations.
Given the lacunae in understanding the genetic variations associated with the spectrum of COVID-19 severity and the risk of PASC in Indian populations, we hypothesized that the genetic factors contributing to acute COVID-19 may also increase vulnerability to PASC, especially through pathways governing cardiovascular and neurological dysfunction. To address this gap, we conducted genome-wide genotyping of a cohort of 60 individuals with a history of SARS-CoV-2 infection in southern India using Infinium Global Screening Array v3 (GSA v3). These data were integrated with clinical and genomic datasets from 474 COVID-19 patients from the Gujarat Biotechnology Research Centre (GBRC), forming the largest Indian COVID-19 host-genome dataset to date. Leveraging this resource, we explored candidate genetic variants and molecular pathways associated with COVID-19 severity and risk of PASC among Indian populations.
Methods
Data acquisition
Saliva samples were collected from 60 individuals with a history of COVID-19 (YenCOVID dataset) at Yenepoya (deemed to be University), Mangalore, India. This study was approved by the institutional ethics committee (YEC-1/2021/034 and YEC-1/2023/236). Based on a self-reported questionnaire for clinical symptoms, these individuals were classified as asymptomatic, mild, moderate, and severe (Supplementary Table S1). The questionnaire covered COVID-19 symptoms, treatment regimens, PASC symptoms (if any), demographic details, personal medical and infection history, family medical history, and vaccination and travel details. Individuals were classified as PASC-positive if they reported ≥1 persistent symptom ≥3 months after acute infection onset, lasting ≥2 months without an alternative clinical explanation, in accordance with the WHO definition (Supplementary Table S2). Genomic DNA was extracted from the saliva samples and genotyped using the Infinium Global Screening Array-24 v3.0 BeadChip platform, which analyzed 648,465 SNVs. The YenCOVID data are reposited in the Science Data Bank (https://www.scidb.cn), with restricted access.
Genomic data and associated demographic and medical history details were obtained from the Gujarat Biotechnology Research Centre (GBRC). This dataset included genotyping data assessing 804,934 SNVs from 474 anonymized COVID-19 patients, who were genotyped using the Axiom Affymetrix genotyping array. It was merged with the YenCOVID dataset, and the combined dataset is known as GBRC + YenCOVID. It included 534 individuals and focused on 104,741 SNVs, which were common to both datasets. VCFtools v0.1.16 (Danecek et al., 2011) and PLINK v1.9 (Purcell et al., 2007) were utilized for all file conversions and data manipulations.
The symptoms reported by individuals in the GBRC and YenCOVID datasets included severe sore throat, dysphagia, fever, anosmia and ageusia, myalgia, headache, fatigue, nausea, cough, rhinorrhea, dyspnea, reduced appetite, respiratory distress, acute gastrointestinal symptoms, claustrophobia/anxiety, cognitive impairment, and cerebral thrombosis. Based on participants’ responses, we applied the criteria outlined in Supplementary Table S1 to categorize them into two groups: 317 were classified as asymptomatic/mild (controls), and 217 were classified as moderate/severe (cases).
The YenCOVID data were further supplemented with a control genomic dataset from Genome Asia 100K (GaSP) (100 Kconsortium, 2019), which included whole-genome data with 66,891,231 SNVs from 1,163 anonymized individuals of predominantly South and East Asian ancestry, including Indian populations, to generate a combined dataset (GaSP + YenCOVID) with 1,223 individuals. We focused on 553,102 SNVs that were common to both datasets (Figure 1).
Figure 1. Schematic diagram of the distribution of participants recruited in the study.
Genome-wide association study
We conducted a genome-wide association study (GWAS) in two different cohorts with distinct objectives. In the first cohort, using the GBRC + YenCOVID dataset, we aimed to identify genetic variants with significant frequency differences between moderate/severe and asymptomatic/mild COVID-19 patients (severity cohort). In the second cohort, we aimed to identify genetic variants with significant frequency differences between individuals with and without PASC using the GaSP + YenCOVID dataset. All individuals from the GaSP dataset were considered controls (PASC cohort). Standard case–control-based association analyses were performed in PLINK v1.9 using the --assoc command. In view of the modest sample size and exploratory nature of our population-specific analysis, we applied a suggestive significance threshold of p < 1 × 10−4 for primary variant selection (Hammond et al., 2021), consistent with prior COVID-19 GWAS frameworks that used relaxed thresholds for initial discovery (Ferreira et al., 2022; Lammi et al., 2025). Genome-wide significance thresholds were subsequently considered for replication-level prioritization. The −log10Ps of all assessed SNVs were plotted as Manhattan plots using the ‘qqman’ package in R v3.5.2. Significant SNVs were annotated using the SNVnexus (https://www.SNV-nexus.org/v4/, 12.12.2024) web-based server for GRCh38/hg38 (Oscanoa et al., 2020).
Before performing GWAS for the PASC cohort, the population structure was assessed within the GaSP + YenCOVID dataset using principal component analysis (PCA) implemented in PLINK v1.9 with the --pca command. The first two principal components (PC1 and PC2) were plotted in RStudio v1.4.1717 (Figure 2). To control for population stratification and avoid confounding due to genetic makeup, we restricted our analysis to 698 individuals of South Asian origin. Of the 698 individuals, those reporting PASC were treated as cases (N = 37), and the remaining were utilized as controls (N = 661).
Figure 2. PCA of the GaSP + YenCOVID dataset. We restricted our downstream analysis to 698 South Asians (inset), comprised of individuals having post-acute sequelae of SARS-CoV-2 infection (PASC) (N = 37), individuals without PASC (N = 23), and population control from the GaSP dataset (N = 638). PC1 and PC2 explain major ancestral substructure; clustering indicates the subset selected for South Asian-specific analysis. We removed all non-South Asian samples in the dataset using PCA.
Transcriptomic analysis
Golden Syrian hamsters (GSHs) (Mesocricetus auratus), one of the small animal models, are widely used to study the disease pathogenesis of SARS-CoV-2 and its variants (Mohandas et al., 2021; Case et al., 2023; Furusawa et al., 2023; Kaur Sardarni et al., 2025; Rajaiah et al., 2024). To compare human data with animal models as described previously (Pandey et al., 2021; Poli et al., 2024; Rajaiah et al., 2024), hamsters (aged 6–8 weeks) were inoculated with the SARS-CoV-2 Omicron variant (Lineage B.1.1.529; Omicron Variant; # NR-56481 obtained from BEI Resources) and necropsied at week 5 post-infection to model PASC in humans (Frere et al., 2022). The number of samples used for transcriptomic analyses was as follows: young male lung, N = 3 for both controls and infected; young male brain, N = 3 for both controls and infected. The sample size was restricted to N = 3 per group to comply with ethical and biosafety restrictions on BSL-3 SARS-CoV-2 work. In our previous study, we demonstrated that GSHs showed differential immunometabolic responses to Omicron and delta variants of SARS-CoV-2 during acute infection (Rajaiah et al., 2024; Kaur Sardarni et al., 2025). Although genotyping data are not available, most infections in the clinical setup likely occurred during the Omicron-dominant wave in India, based on epidemiological timelines (Chavda et al., 2023; Triambak et al., 2023). Therefore, to model human disease pathogenesis and understand the molecular mechanisms underlying the development of PASC in our clinical cohort, we infected the GSHs with Omicron variants of SARS-CoV-2.
We performed the transcriptomic profiling of lung and brain tissues using RNA. One microgram of RNA per sample was used to prepare the rRNA-depleted cDNA library. The sequencing libraries were then generated and subjected to sequencing on an Illumina NovaSeq 6000 platform, generating 150 bp paired end reads. The adapter trimmed FASTQ files were aligned with the Mesocricetus Auratus reference genome (Mesocricetus_auratus.MesAur1.0.111. gtf) retrieved from Ensembl using STAR (v2.7.9a). The differential gene expression analysis of the SARS-CoV-2-infected GSH vs. uninfected controls was performed using the DESeq2 package in R (Love et al., 2014). The sequence data used in this study are available with NCBI SRA under BioProject number PRJNA1196444 (BioProject accession # PRJNA1222984).
Population-specific variation in genetic predisposition toward PASC
Well-known polygenic risk score (PRS) estimation software, PRSice-2 (https://choishingwan.github.io/PRSice) (Choi and O'Reilly, 2019), was used to estimate population-specific PRS for PASC among individuals in the GaSP dataset. The GWAS summary statistics of PASC were obtained from an existing dataset (Lammi et al., 2025) that included 6,450 PASC cases and 1,093,995 population controls from 24 studies across 16 countries. This summary statistics file was used as the reference (--base) input for PRS computation. The effect sizes (beta values) and corresponding standard errors of the SNVs were extracted from the GWAS summary statistics file.
Results
Association of intrinsic and extrinsic risk factors with symptomatic COVID-19 and mortality
First, we utilized the demographic and medical history data from GBRC to examine the association between preexisting comorbidities and an increased risk of symptomatic COVID-19 and associated mortality (Table 1). Individuals with type 2 diabetes had an 8.8-fold increased risk of developing symptomatic COVID-19 (p < 0.0001). Those with heart disease faced a 14.7-fold higher risk (p < 0.0001), and people with hypertension had a 16-fold elevated risk (p < 0.0001) of developing symptomatic SARS-CoV-2 infection. Pulmonary disorders were associated with a 6.6-fold higher risk of symptomatic COVID-19 (p < 0.0001).
Table 1. Association between various demographic and other intrinsic and extrinsic risk factors with symptomatic COVID-19 and its mortality.
Age emerged as a significant risk factor for COVID-19 mortality, with older patients having a 4.3-fold increased risk of death (p < 0.0001) (Table 1). In contrast, gender was not a significant predictor of COVID-19-related mortality (p = 0.0920). Subjects with preexisting conditions, such as type 2 diabetes, faced a 2.4-fold higher risk (p = 0.0004), and those with heart disease had a 3.7-fold increased chance (p < 0.0001) of mortality. Pulmonary disorders were linked to a 3-fold increase in COVID-19-related mortality (p < 0.0009). Symptoms such as cough, dyspnea, chest pain, and nausea exacerbated the risk of mortality by approximately 2-fold (p < 0.0048), 4.4-fold (p < 0.0001), 3.5-fold (p < 0.0022), and 2.5-fold (p < 0.0495), respectively (Table 1).
Consistent with trends in global populations (Richardson et al., 2020; Dessie and Zewotir, 2021), old age and the presence of pre-existing comorbidities, such as type 2 diabetes, cardiovascular diseases, hypertension, and pulmonary complications, significantly exacerbated the risk of hospitalization and mortality among COVID-19 patients in India. However, unlike some studies (Nguyen et al., 2021), male gender was not significantly associated with adverse COVID-19 outcomes in our cohort.
These clinical and demographic findings formed the basis of further GWAS on two separate cohorts: (1) the first (severity cohort) utilized the GBRC + YenCOVID dataset (see Methods), comparing moderate/severe and asymptomatic/mild COVID-19 to identify genetic variants associated with COVID-19 severity; (2) the second (PASC cohort) utilized the GaSP + YenCOVID dataset (see methods), comparing individuals with and without PASC, and aimed to identify genetic variants that predispose to post-acute sequelae. Participants in the GaSP dataset were treated as controls for the PASC cohort.
GWAS examining COVID-19 severity
We examined the genomes of asymptomatic/mild COVID-19 patients (N = 317; controls) versus those that are moderate/severe (N = 217 cases) using the GBRC + YenCOVID dataset. Out of 1,04,741 SNVs used in genome-wide analysis, 3,148 autosomal SNVs across 2,116 genes showed significant association with the severity of COVID-19 (p < 0.0001) (Figure 3). SNVs showing highly significant association (p < 0.0001) mapped to pathways related to neuronal signaling, axon guidance, neural cell adhesion molecule interactions and acetylation, extracellular matrix (ECM) organization, olfactory signaling, Rho-GTPase cycle, and G-
Figure 3. Manhattan plot summarizing GWAS results for the severity of COVID-19. The X-axis represents chromosomes (chr 1 to chr 22). SNVs present in the chromosomes are designated with dots. Negative log-transformed (−log10) multiple-testing-corrected p-values are plotted on the Y-axis. Genomes from 217 patients with moderate/severe symptoms were compared with those from 317 asymptomatic/mild patients. Of 1,04,741 SNVs used, 3,148 SNV markers revealed highly significant variation between asymptomatic/mild and moderate/severe cases. The SNVs with p < 0.00001 are indicated with the blue line, and those with p < 0.0000001 are indicated with the red line.
GWAS assessing PASC
We tested genomes of individuals of Asian ancestry from the GenomeAsia database (N = 661; controls) against those who reported PASC (N = 37; cases) using the GaSP + YenCOVID dataset, followed by PCA correction (see Methods). Of the 5,53,102 SNVs used in genome-wide analysis, 8,247 autosomal SNVs in 4,769 candidate genes showed significant association with PASC (p < 0.0001) (Figure 4).
Figure 4. Manhattan plot summarizing GWAS results for the PASC. The X-axis represents chromosomes (chr 1–22). SNVs present in the chromosomes are designated with dots. Negative log-transformed (−log10) multiple-testing-corrected p-values are plotted on the Y-axis. A total of 37 COVID-19 patient genomes with PASC were compared with 661 without PASC, evaluating 5,53,102 SNVs. Among these, 8247 SNV markers revealed highly significant variation between individuals with and without PASC. The SNVs with p < 0.00001 are indicated with the blue line, and those with p < 0.0000001 are indicated with the red line.
SNVs showing highly significant association (p < 0.0001) were associated with pathways such as neuronal development, immune and cytokine signaling, olfactory transduction, and G-protein-coupled receptor (GPCR) signaling, along with infectious disease, ECM organization, and telomere maintenance (Supplementary Figure S3). Candidate genes harboring highly significant SNVs were enriched in GO terms (biological processes) such as neurodevelopment, neurogenesis, and neurodifferentiation (Supplementary Figure S4) that highlight a strong association between PASC-linked genes and the nervous system among Indian populations.
We identified 806 candidate genes shared between the severity and PASC cohorts. Among these, 30 protein-coding genes are associated with neuropsychiatric disorders (Table 2), while 23 genes were linked to cardiovascular conditions (Table 3). Interestingly, calcium voltage-gated channel subunit alpha1 C (CACNA1C), solute carrier family 8 member A1 (SLC8A1), G protein-coupled receptor kinase 5 (GRK5), phosphodiesterase 4B (PDE4B), and leucine-rich repeat kinase 2 (LRRK2) were common to both categories, suggesting overlapping molecular mechanisms in neurological and cardiac pathophysiology.
Table 2. Candidate protein-coding neuropsychiatric genes common to both the severity and PASC cohorts.
Table 3. Candidate protein-coding cardiovascular genes common to both the severity and PASC cohorts.
Notably, 14 of the 54 highly significant genes prioritized by the COVID-19 Host Genetics Initiative (HGI) Consortium (Kanai et al., 2023) were also identified in either the severity or the PASC cohort or both, underscoring a strong concordance between our results and global COVID-19 host-genetic evidence (Table 4). Anoctamin 1 (ANO1), along with protein kinase AMP-activated catalytic subunit alpha 2 (PRKAA2/AMPK), heat shock protein family B (small) member 7 (HSPB7), potassium voltage-gated channel subfamily Q member 1 (KCNQ1), and von Willebrand factor (VWF), was unique to the PASC cohort. Furthermore, four PASC-linked candidate genes in the GPCR pathway were identified in the PASC cohort (Supplementary Table S3).
Table 4. Comparison of candidate genes identified in the severity and exploratory PASC cohorts that overlap with highly significant loci reported by the COVID-19 host genetics initiative consortium.
Transcriptional profiling following SARS-CoV-2 infection
Transcriptional profiling was performed using RNA sequencing (RNAseq) on brain and lung tissues obtained from SARS-CoV-2 and mock-infected hamsters. A stringent threshold (p < 10−5) was applied to reduce false positives given the exploratory sample size (N = 3 per group), which adhered to ethical principles of minimal animal use. The differential expression pattern of candidate genes between control and infected hamsters is summarized in the heatmap (Figure 5). In the lung, 115 genes were significantly downregulated (p < 10−5), and 140 genes were significantly upregulated (p < 10−5) (Supplementary Figure S5a). In the brain, 205 and 271 genes were significantly downregulated and upregulated, respectively (p < 10−5) (Supplementary Figure S5b). Among the differentially expressed candidate genes, 32 downregulated and 33 upregulated in the brain overlapped with those identified in the exploratory PASC GWAS cohort (Table 5). Similarly, 8 downregulated and 30 upregulated candidate genes in the lung were also identified in the PASC cohort (Table 6).
Figure 5. Heatmaps summarizing the differential expression pattern of candidate genes between control and SARS-CoV-2-infected hamsters in (a) lung and (b) brain tissues. These genes were also identified in the exploratory PASC cohort. Upregulation and downregulation are shown by gradients of red and blue, respectively.
Table 5. Significantly upregulated and downregulated (p < 0.00001) candidate genes in the brains of SARS-CoV-2-infected hamsters were also identified in the exploratory PASC cohort.
Table 6. List of candidate genes that are significantly up- and downregulated (p < 1 × 10−5) in the lungs of SARS-CoV-2-infected hamsters and also identified in the PASC cohort.
Population-specific variation in a genetic predisposition for PASC
The PRS map for PASC represented distinct ethnolinguistic and regional patterns, with considerable individual-specific variation indicated by the standard deviation (Figure 6). Populations such as tribal groups from Central India, Andamanese tribes, Tamilians from Sri Lanka, and Bengalis exhibited relatively elevated PRS, suggesting higher genetic propensity for PASC-related complications. In contrast, populations from North and Northwest India depicted comparatively lower polygenic risk. Populations from Southern India displayed pronounced within-group variation in genetic risk for PASC, suggesting group-specific genetic vulnerability rather than broad regional trends.
Figure 6. Polygenic risk score (PRS) for PASC among various South Asian populations. PRS was calculated using PRSice v2. PRS are divided into four quartiles: Q1 (low), Q2 (medium), Q3 (high), and Q4 (very high). The standard deviation (SD) of PRS is shown by the size of the circles.
Discussion
This study represents one of the first efforts aimed to dissect the genetic architecture underlying COVID-19 severity and its long-term sequelae in Indian populations. Our framework, combining two complimentary GWASs and integrative transcriptomic analysis, revealed convergent mechanisms and biological pathways that may underlie post-viral cardiovascular and neurological outcomes. The findings suggest that host genetic factors associated with severe acute COVID-19 may contribute to long-term vulnerability to PASC. While the limited sample-size renders the PASC–GWAS exploratory, identification of similar trends across several independent layers of data supports their biological plausibility.
Integrative view of COVID-19 severity and susceptibility to PASC
Across both GWAS models, we uncovered variants that mapped to candidate loci influencing ECM organization, vesicular trafficking, and stress-response networks, which are not only central to crucial physiological processes, namely, cell differentiation, development, and metabolism, but also pivotal for modulation of tissue remodeling, homeostasis, and immune responses post-infection (Su et al., 2024). Accordingly, rather than representing isolated effects, these observations may allude to a global dysregulation of the cellular resilience mechanism that persists following an incomplete resolution of the SARS-CoV-2 infection and precipitates into long-term pathology.
Extensive evidence supports a bidirectional molecular axis linking the brain and the heart, wherein neural, endocrine, and inflammatory signals coordinate autonomic regulation, cardiac contractility, and metabolic adaptation (Plott et al., 2024; Ajijola et al., 2025). Congruently, disruption of the neurocardiac axis by SARS-CoV-2 infection may cause neurological and cardiovascular phenotypes, among others, as observed in PASC.
Synaptic adhesion, axon guidance, and neurodevelopment
Multiple candidate loci that emerged from both cohorts and are central to synaptic organization and neurodevelopment include contactin-associated protein 2 (CNTNAP2), which belongs to the neurexin superfamily of synaptic transmembrane adhesion molecules and is highly expressed in the brain (Kleijer et al., 2015; St. George-Hyslop et al., 2022). It is involved in the organization of myelinated neurons (Gordon et al., 2014) and neural circuit assembly (Anderson et al., 2012) and is strongly associated with susceptibility to neurodevelopmental disorders (NDDs), such as specific language impairment (SLI), autism spectrum disorder (ASD), schizophrenia, and depression (Alarcón et al., 2008; Chiocchetti et al., 2015; Fang et al., 2021). ADAM metallopeptidase with thrombospondin type 1 motif 17 (ADAMTS17) encodes a secreted metalloprotease that is highly expressed in the brain and retina (Morales et al., 2009) and is implicated in ECM remodeling and organization, as well as in a hereditary eye disease (Hubmacher et al., 2017). Amyloid beta precursor protein (APP) encodes a transmembrane protein with essential roles in many neurodevelopmental processes, such as neurogenesis, neurite outgrowth, axonal guidance, and synaptogenesis, and is central to the pathogenesis of Alzheimer’s disease (AD) (Chau et al., 2023).
Other loci that emerged from both GWASs with high relevance to CNS include WW domain containing oxidoreductase (WWOX), which has been associated with various complex and rare monogenic brain pathologies, including ASD, intellectual disability (ID), and attention-deficit/hyperactivity disorder (ADHD) (Sanders et al., 2011; Harich et al., 2020), along with AD (Kunkle et al., 2019), multiple sclerosis (MS) (Beecham et al., 2013), spinocerebellar ataxia type 12 (SCAR12; OMIM #614322), and WWOX-related epileptic encephalopathy syndrome (OMIM #616211) (Aldaz and Hussain, 2020). Membrane-associated guanylate kinase, WW, and PDZ domain-containing 1 and 2 (MAGI1 and MAGI2) function as scaffolds for nerve growth factor signaling and the recruitment of neurotransmitter receptors, such as α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)- and N-methyl-D-aspartate (NMDA)-type glutamate receptors, neuroligins, and β-dystroglycan, at glutamatergic and GABAergic synapses, respectively (Deng et al., 2006; Sassoè-Pognetto et al., 2011).
Notable neuronal candidate genes whose expressions were significantly altered in the transcriptomes from SARS-CoV-2-infected hamster brains and lungs and those also identified in the PASC cohort included calcium voltage-gated channel auxiliary subunit gamma 3 (CACNG3), an AMPA receptor regulator whose dysregulation in the entorhinal cortex may underlie the pathogenesis of AD (Jia et al., 2021). It has also been predicted as significantly deregulated in gene expression datasets from COVID-19, AD, and Parkinson’s disease (PD) (Shi et al., 2023). Gamma-aminobutyric acid type A receptor subunit alpha6 (GABRA6), although its polymorphisms are not directly implicated in neuropsychological issues, can trigger anxiety and depression symptoms when exposed to stress (Gonda et al., 2017).
ECM-related loci that emerged from PASC GWAS include brain abundant membrane-attached signal protein 1 (BASP1) (Iino et al., 1999; Maekawa et al., 1999; Frey et al., 2000) and Abl interactor 2 (ABI2) (Grove et al., 2004) that encode modulators of the actin cytoskeleton abundant in various brain regions, such as the cerebral cortex, cerebellum, hypothalamus, and olfactory bulb, with essential roles in neurite outgrowth, dendritic spine morphology, density, neuronal migration, synaptic plasticity, and axon regeneration. Decreased BASP1 levels have also been detected in AD (Musunuri et al., 2014). This cohort also identified leucine-rich repeat transmembrane neuronal 3 (LRRTM3), which encodes a trans-synaptic adhesion molecule involved in excitatory synaptic assembly, connectivity, and plasticity (Um et al., 2016; Kim et al., 2022); its variants are associated with ASD among Indians (Dutta et al., 2023) and other populations (Sousa et al., 2010). The PASC GWAS also detected candidate genes modulating myelination by regulating intercell connectivity—for example, contactin-associated protein 1 (CNTNAP1) (Bhat et al., 2001; Gordon et al., 2014), fibulin-2 (FBLN2) (Ghorbani et al., 2024), and tenascin C (TNC) (Xie et al., 2013; Heneka et al., 2015; Tucić et al., 2021).
Cardiac and neuronal findings
Two loci identified through both GWASs that have known overlapping roles in both the heart and brain are as follows: Unc-5 netrin receptor C (UNC5C), a netrin signaling receptor highly expressed in the adult CNS and heart that is involved in axon guidance and repulsion of neuronal growth cones (Kim and Ackerman, 2011; Poliak et al., 2015), and its variants are associated with an increased risk of AD (Ridge et al., 2016); catenin alpha 3 (CTNNA3) encodes αT-catenin, a molecular linker for desmosomal and adherens junctions in the area composite of the vertebrate heart; it is linked to genetic dilated cardiomyopathy manifesting with ventricular arrhythmia, severe heart failure, and an increased risk of sudden death (Janssens et al., 2003), and it is also associated with a higher risk of ASD (Bacchelli et al., 2014).
From the PASC-only cohort, we found several candidates with known functions in the heart and CNS: apolipoprotein B (APOB), a carrier for clinically significant lipids, such as low-density lipoprotein (LDL), which not only has a strong genetic association with susceptibility to heart disease and stroke (Richardson et al., 2021) but whose rare variants are also associated with early-onset AD (Wingo et al., 2019). A-kinase anchoring protein 9 (AKAP9) is a scaffolding protein involved in protein kinase A activation (Piggott et al., 2008), leading to tau hyperphosphorylation, which is a hallmark of AD (Liu et al., 2006). Rare variants in AKAP9 are associated with AD (Logue et al., 2014) and cardiac abnormalities, including long QT syndrome (Chen et al., 2007; Tse et al., 2021). G protein-coupled receptor kinase 5 (GRK5), which plays conserved roles in heart development (Burkhalter et al., 2013), has also been associated with cognitive dysfunction, dementia, type 2 diabetes, chronic inflammation, and heart failure (Hendrickx et al., 2018). Lysine acetyltransferase 6A (KAT6A) is a chromatin modulator associated with a rare genetic NDD characterized by brain, cardiac, and ocular abnormalities, along with growth retardation and ID (Urreizti et al., 2020; Jiang et al., 2021).
Cardiac development
Candidates from the PASC cohort implicated in heart development and function include ryanodine receptor 2 (RYR2) (also identified in the severity cohort) and potassium voltage-gated channel subfamily Q member 1 (KCNQ1), encoding calcium (Ca++) and potassium KvLQT1 (Kv7.1) channels, respectively, and controlling cardiac muscle excitation–contraction coupling. RYR2 pathogenic mutations are associated with rare genetic arrhythmias that can cause sudden cardiac death (Lehnart et al., 2004). Several RYR2 variants also predispose to Ca++ leakage, particularly under conditions of elevated catecholaminergic activity—for example, exercise and emotional stress that, in turn, may result in fatal cardiac arrhythmias (Lehnart et al., 2004; Fowler and Zissimopoulos, 2022). KCNQ1 is one of the most prominent causes of long QT syndrome, leading to an increased risk of sudden and fatal cardiac arrest among young individuals (Goldenberg and Moss, 2008). Other genes include RNA-binding motif protein 20 (RBM20), which controls the expression of genes modulating Ca++ and other ion levels, such as RYR2 (Maatz et al., 2014). Variants in RBM20 are associated with dilated cardiomyopathy that presents with an increased risk of arrhythmias and heart failure at a young age (Haas et al., 2015). Other relevant cardiac loci include desmoglein 2 (DSG2) (Kant et al., 2015), desmoplakin (DSP) (Smith and Fuchs, 1998; Gigli et al., 2019), and titin (TTN) (Herman et al., 2012; LeWinter and Granzier, 2013) identified in both severity and PASC cohorts, and myosin heavy chain 7 (MYH7), identified exclusively in the PASC cohort (Hinton et al., 2010; Yotti et al., 2019; Ritter et al., 2022).
Stress response and proteostasis
Several candidate genes from the stress-response and proteostasis machineries also emerged from the PASC exploratory cohort; these include activating transcription factor 6 (ATF6), a central player in ER stress and the unfolded protein response (Wang et al., 2000), which is activated following stressors such as myocardial ischemia and is known to play a protective role against ischemia/reperfusion damage (Jin et al., 2017); crystallin alpha B (CRYAB), a chaperone expressed at high levels in the brain, heart, skeletal muscle, and eye lens (Basha et al., 2012) and implicated in several types of cardiomyopathies (Thorkelsson and Chin, 2024) and the pathogenesis of MS (van Noort et al., 1995); and immune-modulatory factors such as follistatin-like 1 (FSTL1) (Lara-Pezzi et al., 2008; Li et al., 2011; Wang et al., 2011) and endoplasmic reticulum aminopeptidase 1(ERAP1) (Mattorre et al., 2022; Țiburcă et al., 2024).
Population-specific polygenic risk and translational relevance
Beyond locus-level findings, PRS analysis suggests significant inter-population variation in the cumulative risk burden for PASC. Cardiovascular complications and related fatalities have become a prominent healthcare concern in India in the post-COVID-19 era, frequently highlighted in the public discourse, even though their systematic monitoring has been limited. Distinct allele-frequency distributions across Indian populations emphasize ancestry-linked heterogeneity in host genomic susceptibility. This variation could partly explain the observed clinical diversity in PASC manifestations and underscore the importance of including underrepresented populations in global genomics consortia. From a translational perspective, ancestry-informed PRS frameworks could serve as predictive tools that prioritize individuals at a higher risk of neuro-cardiac sequelae following viral infection. Integrating genetic data with longitudinal clinical monitoring, autonomic testing, and imaging biomarkers would accelerate the transition from discovery to precision-medicine applications in post-COVID-19 care.
Limitations and future directions
The exploratory PASC GWAS was constrained by its sample size (N = 37), limiting statistical power and necessitating careful and conservative interpretation. The use of population controls without information on their PASC status risks misclassification, thereby attenuating the observed effect sizes. The accrual of PASC patients was limited by challenges in patient recruitment and clinical follow-up, which are common in low- and medium-income countries. Since ethical principles constrained the hamster sample size, the transcriptomic results should also be interpreted as hypothesis-generating. Furthermore, although the WHO diagnostic criteria for PASC were followed, symptom overlap with alternative clinical conditions cannot be fully excluded, which may contribute to some degree of outcome misclassification. Future studies incorporating longitudinal clinical tracking, exclusionary diagnostics, and biomarker-based classification will improve diagnostic accuracy and homogeneity of PASC cohorts.
Nevertheless, this study provides the first genomic evidence from India linking host genetic predisposition for acute COVID-19 severity to the development of PASC, particularly through mechanisms affecting the neuro-cardiac axis. The convergence of human GWAS signals with transcriptional alterations noted in SARS-CoV-2-infected hamster tissues underscores conserved biological pathways underlying the chronic post-viral pathology, thereby lending some credence to the neuro-cardiac hypothesis of PASC. These findings advocate for the urgent need to undertake broader ancestry-inclusive genomic efforts across India and in pan-Asian populations and integrative risk-modeling strategies that combine polygenic susceptibility with clinical and environmental determinants to better predict PASC trajectories. In the future, functional studies using patient-derived cellular models, such as iPSC-generated neurons and cardiomyocytes, will be required to examine how variants in key candidate genes disrupt molecular networks, drive persistent post-COVID-19 manifestations, and guide precision approaches for early intervention.
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: Science Data Bank, at https://www.scidb.cn/en/s/qIbqIr, and NCBI with the accession number PRJNA1222984. GWAS summary statistics are available upon request. Anonymized genotype data of the 60 participants in this study are available upon approval from the institutional ethics committee, Yenepoya Ethics Committee-1.
Ethics statement
The studies involving humans were approved by Yenepoya Ethics Committee-1, Yenepoya (deemed to be University), Mangalore, India. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Animal experiments were approved by the Institutional Animal Ethics Committee: University of Nebraska Medical Center (21-019-06-FC) conducted in BSL-3/ABSL-3 facilities, and adhered to national/international animal welfare guidelines.
Author contributions
PUS: Investigation, Writing – review and editing, Software, Methodology, Data curation, Visualization, Formal analysis. HU: Conceptualization, Resources, Investigation, Supervision, Writing – review and editing, Funding acquisition, Project administration. AA: Visualization, Data curation, Writing – review and editing, Investigation, Software. PS: Investigation, Visualization, Data curation, Software, Formal analysis, Writing – review and editing. US: Validation, Visualization, Investigation, Data curation, Software, Writing – review and editing, Formal analysis, Methodology. NK: Methodology, Visualization, Validation, Investigation, Software, Formal analysis, Writing – review and editing. AA: Validation, Writing – review and editing, Investigation, Project administration, Methodology, Funding acquisition, Visualization, Supervision. SB: Conceptualization, Resources, Investigation, Funding acquisition, Project administration, Validation, Writing – review and editing, Supervision. PU: Methodology, Supervision, Conceptualization, Investigation, Validation, Resources, Writing – original draft, Project administration. RD: Data curation, Supervision, Methodology, Software, Investigation, Resources, Formal analysis, Conceptualization, Validation, Project administration, Writing – review and editing.
Funding
The authors declare that financial support was received for the research and/or publication of this article. This study was partially funded by the Yenepoya (deemed to be University) Seed Grant to HU (YU/Seed Grant/110-2022). This work was also partially supported by the Nebraska Research Initiative (NRI) grants at the University of Nebraska and Otis Glebe Medical Research Foundation award to SNB and the Eugene Kenney Memorial Fund from UNMC College of Medicine to Dr. Arpan Acharya.
Acknowledgements
The authors thank Yenepoya (deemed to be University) for providing the financial support in the form of a Seed Grant to Dr. Hrushikesh Udupa (YU/Seed Grant/110-2022). The authors thank the staffs of the Yenepoya Research Centre and Yenepoya Medical College for their help and support during sample collection. The authors also thank the University of Nebraska Medical Center (UNMC) BSL-3 and ABSL-3 facility administrators for their support in performing the SARS-CoV-2 infection experiments involving golden Syrian hamsters. These facilities are administered by the office of the vice chancellor for research and supported by the Nebraska Research Initiative (NRI). The authors thank all the current and past members of Byrareddy’s laboratory for their technical supports. The authors also thank the UNMC comparative medicine research technical staffs for assisting with the hamster experiments.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Correction note
This article has been corrected with minor changes. These changes do not impact the scientific content of the article.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fgene.2025.1696764/full#supplementary-material
References
Ajčević, M., Iscra, K., Furlanis, G., Michelutti, M., Miladinović, A., Buoite Stella, A., et al. (2023). Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci. Rep. 13, 5808. doi:10.1038/s41598-023-32275-3
Ajijola, O. A., Aksu, T., Arora, R., Biaggioni, I., Chen, P.-S., De Ferrari, G., et al. (2025). Clinical neurocardiology: defining the value of neuroscience-based cardiovascular therapeutics – 2024 update. J. Physiology 603, 1781–1839. doi:10.1113/JP284741
Al-Aly, Z., Bowe, B., and Xie, Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28, 1461–1467. doi:10.1038/s41591-022-01840-0
Alarcón, M., Abrahams, B. S., Stone, J. L., Duvall, J. A., Perederiy, J. V., Bomar, J. M., et al. (2008). Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 82, 150–159. doi:10.1016/j.ajhg.2007.09.005
Aldaz, C. M., and Hussain, T. (2020). WWOX loss of function in neurodevelopmental and neurodegenerative disorders. Int. J. Mol. Sci. 21, 8922. doi:10.3390/ijms21238922
Anderson, G. R., Galfin, T., Xu, W., Aoto, J., Malenka, R. C., and Südhof, T. C. (2012). Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development. Proc. Natl. Acad. Sci. U. S. A. 109, 18120–18125. doi:10.1073/pnas.1216398109
Atkins, A., Xu, M. J., Li, M., Rogers, N. P., Pryzhkova, M. V., and Jordan, P. W. (2020). SMC5/6 is required for replication fork stability and faithful chromosome segregation during neurogenesis. Elife 9, e61171. doi:10.7554/eLife.61171
Author Anonymous (2022). Post COVID-19 condition (long COVID). Available online at: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (Accessed December 6th, 2024 2024).
Ayoubkhani, D., Bosworth, M. L., King, S., Pouwels, K. B., Glickman, M., Nafilyan, V., et al. (2022). Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a Coronavirus disease 2019 vaccine: Community-Based, matched cohort Study. Open Forum Infect. Dis. 9, ofac464. doi:10.1093/ofid/ofac464
Bacchelli, E., Ceroni, F., Pinto, D., Lomartire, S., Giannandrea, M., D'adamo, P., et al. (2014). A CTNNA3 compound heterozygous deletion implicates a role for αT-catenin in susceptibility to autism spectrum disorder. J. Neurodev. Disord. 6, 17. doi:10.1186/1866-1955-6-17
Ballering, A. V., Van Zon, S. K. R., Olde Hartman, T. C., and Rosmalen, J. G. M.Lifelines Corona Research Initiative (2022). Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400, 452–461. doi:10.1016/S0140-6736(22)01214-4
Basha, E., O’neill, H., and Vierling, E. (2012). Small heat shock proteins and α-crystallins: dynamic proteins with flexible functions. Trends Biochemical Sciences 37, 106–117. doi:10.1016/j.tibs.2011.11.005
Basu, A., Sarkar-Roy, N., and Majumder, P. P. (2016). Genomic reconstruction of the history of extant populations of India reveals five distinct ancestral components and a complex structure. Proc. Natl. Acad. Sci. U. S. A. 113, 1594–1599. doi:10.1073/pnas.1513197113
Beecham, A., Patsopoulos, N., Xifara, D., Davis, M., Kemppinen, A., Cotsapas, C., et al. (2013). International Multiple Sclerosis Genetics Consortium (IMSGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 45, 1353–1360. doi:10.1038/ng.2770
Bhat, M. A., Rios, J. C., Lu, Y., Garcia-Fresco, G. P., Ching, W., St Martin, M., et al. (2001). Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron 30, 369–383. doi:10.1016/s0896-6273(01)00294-x
Bossi, G., Giordano, G., Rispoli, G. A., Maggiore, G., Naturale, M., Marchetti, D., et al. (2017). Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene. Pediatr. Rep. 9, 7266. doi:10.4081/pr.2017.7266
Burkhalter, M. D., Fralish, G. B., Premont, R. T., Caron, M. G., and Philipp, M. (2013). Grk5l controls heart development by limiting mTOR signaling during symmetry breaking. Cell Reports 4, 625–632. doi:10.1016/j.celrep.2013.07.036
Cai, M., Xie, Y., Topol, E. J., and Al-Aly, Z. (2024). Three-year outcomes of post-acute sequelae of COVID-19. Nat. Med. 30, 1564–1573. doi:10.1038/s41591-024-02987-8
Case, J. B., Scheaffer, S. M., Darling, T. L., Bricker, T. L., Adams, L. J., Harastani, H. H., et al. (2023). Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters. J. Virol. 97, e0062823. doi:10.1128/jvi.00628-23
Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., et al. (2022). Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain, Behav. Immun. 101, 93–135. doi:10.1016/j.bbi.2021.12.020
Chamnanphon, M., Pongpanich, M., Suttichet, T. B., Jantarabenjakul, W., Torvorapanit, P., Putcharoen, O., et al. (2022). Host genetic factors of COVID-19 susceptibility and disease severity in a Thai population. J. Hum. Genet. 67, 295–301. doi:10.1038/s10038-021-01009-6
Chau, D.D.-L., Ng, L.L.-H., Zhai, Y., and Lau, K.-F. (2023). Amyloid precursor protein and its interacting proteins in neurodevelopment. Biochem. Soc. Trans. 51, 1647–1659. doi:10.1042/BST20221527
Chaudhry, D., Khandelwal, S., Bahadur, C., Daniels, B., Bhattacharyya, M., Gangakhedkar, R., et al. (2024). Prevalence of long COVID symptoms in Haryana, India: a cross-sectional follow-up study. Lancet Regional Health - Southeast Asia 25, 100395. doi:10.1016/j.lansea.2024.100395
Chavda, V. P., Balar, P., Vaghela, D., Solanki, H. K., Vaishnav, A., Hala, V., et al. (2023). Omicron variant of SARS-CoV-2: an Indian perspective of vaccination and management. Vaccines (Basel) 11, 160. doi:10.3390/vaccines11010160
Chen, L., Marquardt, M. L., Tester, D. J., Sampson, K. J., Ackerman, M. J., and Kass, R. S. (2007). Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc. Natl. Acad. Sci. 104, 20990–20995. doi:10.1073/pnas.0710527105
Chen, R., Zhang, Q., Duan, X., York, P., Chen, G.-D., Yin, P., et al. (2017). The 5-Hydroxymethylcytosine (5hmC) reader UHRF2 is required for normal levels of 5hmC in Mouse adult brain and spatial learning and memory. J. Biol. Chem. 292, 4533–4543. doi:10.1074/jbc.M116.754580
Chiocchetti, A. G., Kopp, M., Waltes, R., Haslinger, D., Duketis, E., Jarczok, T. A., et al. (2015). Variants of the CNTNAP2 5′ promoter as risk factors for autism spectrum disorders: a genetic and functional approach. Mol. Psychiatry 20, 839–849. doi:10.1038/mp.2014.103
Chivukula, A. S., Suslova, M., Kortzak, D., Kovermann, P., and Fahlke, C. (2020). Functional consequences of SLC1A3 mutations associated with episodic ataxia 6. Hum. Mutat. 41, 1892–1905. doi:10.1002/humu.24089
Choi, S. W., and O'reilly, P. F. (2019). PRSice-2: polygenic risk Score software for biobank-scale data. GigaScience 8, giz082. doi:10.1093/gigascience/giz082
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., et al. (2023). Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol. and Ther. 244, 108373. doi:10.1016/j.pharmthera.2023.108373
Crivelli, L., Palmer, K., Calandri, I., Guekht, A., Beghi, E., Carroll, W., et al. (2022). Changes in cognitive functioning after COVID-19: a systematic review and meta-analysis. Alzheimer's and Dementia 18, 1047–1066. doi:10.1002/alz.12644
Danecek, P., Auton, A., Abecasis, G., Albers, C. A., Banks, E., Depristo, M. A., et al. (2011). The variant call format and VCFtools. Bioinformatics 27, 2156–2158. doi:10.1093/bioinformatics/btr330
Davis, H. E., Mccorkell, L., Vogel, J. M., and Topol, E. J. (2023). Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133–146. doi:10.1038/s41579-022-00846-2
Dehghan, M., Mirzohreh, S. T., Kaviani, R., Yousefi, S., and Pourmehran, Y. (2024). A deeper look at long-term effects of COVID-19 on myocardial function in survivors with no prior heart diseases: a GRADE approach systematic review and meta-analysis. Front. Cardiovasc Med. 11, 1458389. doi:10.3389/fcvm.2024.1458389
Deming, Y., Filipello, F., Cignarella, F., Cantoni, C., Hsu, S., Mikesell, R., et al. (2019). The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk. Sci. Translational Medicine 11, eaau2291. doi:10.1126/scitranslmed.aau2291
Deng, F., Price, M. G., Davis, C. F., Mori, M., and Burgess, D. L. (2006). Stargazin and other transmembrane AMPA receptor regulating proteins interact with synaptic scaffolding protein MAGI-2 in brain. J. Neurosci. 26, 7875–7884. doi:10.1523/JNEUROSCI.1851-06.2006
Dessie, Z. G., and Zewotir, T. (2021). Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect. Dis. 21, 855. doi:10.1186/s12879-021-06536-3
Douaud, G., Lee, S., Alfaro-Almagro, F., Arthofer, C., Wang, C., Mccarthy, P., et al. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604, 697–707. doi:10.1038/s41586-022-04569-5
Dutta, N., Saha, S., Chatterjee, M., Sinha, S., and Mukhopadhyay, K. (2023). LRRTM3 genetic variations, rs1925575, and rs1925608 contributed to autism spectrum Disorder Trait severity: an observation in the Indian probands. Int. J. Mol. Cell Med. 12, 350–360. doi:10.22088/IJMCM.BUMS.12.4.350
Egan, M. F., Straub, R. E., Goldberg, T. E., Yakub, I., Callicott, J. H., Hariri, A. R., et al. (2004). Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc. Natl. Acad. Sci. 101, 12604–12609. doi:10.1073/pnas.0405077101
Ellinghaus, D., Degenhardt, F., Bujanda, L., Buti, M., Albillos, A., Invernizzi, P., et al. (2020). Genomewide Association Study of severe Covid-19 with respiratory failure. N. Engl. J. Med. 383, 1522–1534. doi:10.1056/NEJMoa2020283
Fang, F., Ge, M., Liu, J., Zhang, Z., Yu, H., Zhu, S., et al. (2021). Association between genetic variants in DUSP15, CNTNAP2, and PCDHA genes and risk of childhood autism spectrum disorder. Behav. Neurol. 2021, 4150926. doi:10.1155/2021/4150926
Ferreira, L. C., Gomes, C. E. M., Rodrigues-Neto, J. F., and Jeronimo, S. M. B. (2022). Genome-wide association studies of COVID-19: connecting the dots. Infect. Genet. Evol. 106, 105379. doi:10.1016/j.meegid.2022.105379
Fonseca, K. L., Maceiras, A. R., Matos, R., Simoes-Costa, L., Sousa, J., Cá, B., et al. (2020). Deficiency in the glycosyltransferase Gcnt1 increases susceptibility to tuberculosis through a mechanism involving neutrophils. Mucosal Immunol. 13, 836–848. doi:10.1038/s41385-020-0277-7
Fowler, E. D., and Zissimopoulos, S. (2022). Molecular, subcellular, and arrhythmogenic mechanisms in genetic RyR2 disease. Biomolecules 12, 1030. doi:10.3390/biom12081030
Frere, J. J., Serafini, R. A., Pryce, K. D., Zazhytska, M., Oishi, K., Golynker, I., et al. (2022). SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 14, eabq3059. doi:10.1126/scitranslmed.abq3059
Frey, D., Laux, T., Xu, L., Schneider, C., and Caroni, P. (2000). Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J. Cell Biology 149, 1443–1454. doi:10.1083/jcb.149.7.1443
Furusawa, Y., Kiso, M., Iida, S., Uraki, R., Hirata, Y., Imai, M., et al. (2023). SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters. EBioMedicine 91, 104561. doi:10.1016/j.ebiom.2023.104561
Gagliardi, S., Gallo, A., Policicchio, S., La Salvia, S., Diamanti, L., Bernuzzi, S., et al. (2016). Environmental and genetic factors in ALS: positive correlation of Snps in flavin-containing monooxygenase 5 gene. Ann. Neurodegener. Disord. 1, 1014.
Gandhi, R. T., Lynch, J. B., and Del Rio, C. (2020). Mild or moderate Covid-19. N. Engl. J. Med. 383, 1757–1766. doi:10.1056/nejmcp2009249
Ghorbani, S., Li, C., Lozinski, B. M., Moezzi, D., D'mello, C., Dong, Y., et al. (2024). Fibulin-2 is an extracellular matrix inhibitor of oligodendrocytes relevant to multiple sclerosis. J. Clin. Invest 134, e176910. doi:10.1172/JCI176910
Gigli, M., Merlo, M., Graw, S. L., Barbati, G., Rowland, T. J., Slavov, D. B., et al. (2019). Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J. Am. Coll. Cardiol. 74, 1480–1490. doi:10.1016/j.jacc.2019.06.072
Goldenberg, I., and Moss, A. J. (2008). Long QT syndrome. J. Am. Coll. Cardiol. 51, 2291–2300. doi:10.1016/j.jacc.2008.02.068
Gonda, X., Sarginson, J., Eszlari, N., Petschner, P., Toth, Z. G., Baksa, D., et al. (2017). A new stress sensor and risk factor for suicide: the T allele of the functional genetic variant in the GABRA6 gene. Sci. Reports 7, 12887. doi:10.1038/s41598-017-12776-8
Gordon, A., Adamsky, K., Vainshtein, A., Frechter, S., Dupree, J. L., Rosenbluth, J., et al. (2014). Caspr and caspr2 are required for both radial and longitudinal organization of myelinated axons. J. Neurosci. 34, 14820–14826. doi:10.1523/JNEUROSCI.3369-14.2014
Grabowski, K., Koplin, G., Aliu, B., Schulte, L., Schulz, A., and Kreutz, R. (2013). Mapping and confirmation of a major left ventricular mass QTL on rat chromosome 1 by contrasting SHRSP and F344 rats. Physiol. Genomics 45, 827–833. doi:10.1152/physiolgenomics.00067.2013
Greene, C., Hanley, N., and Campbell, M. (2020). Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders. Transl. Psychiatry 10, 373. doi:10.1038/s41398-020-01054-3
Grove, M., Demyanenko, G., Echarri, A., Zipfel, P. A., Quiroz, M. E., Rodriguiz, R. M., et al. (2004). ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory. Mol. Cell Biol. 24, 10905–10922. doi:10.1128/MCB.24.24.10905-10922.2004
Haas, J., Frese, K. S., Peil, B., Kloos, W., Keller, A., Nietsch, R., et al. (2015). Atlas of the clinical genetics of human dilated cardiomyopathy. Eur. Heart Journal 36, 1123–1135. doi:10.1093/eurheartj/ehu301
Hammond, R. K., Pahl, M. C., Su, C., Cousminer, D. L., Leonard, M. E., Lu, S., et al. (2021). Biological constraints on GWAS SNPs at suggestive significance thresholds reveal additional BMI loci. Elife 10, e62206. doi:10.7554/eLife.62206
Han, Q., Zheng, B., Daines, L., and Sheikh, A. (2022). Long-Term sequelae of COVID-19: a systematic review and meta-analysis of one-year Follow-Up studies on Post-COVID symptoms. Pathogens 11, 269. doi:10.3390/pathogens11020269
Harding, J. L., Oviedo, S. A., Ali, M. K., Ofotokun, I., Gander, J. C., Patel, S. A., et al. (2023). The bidirectional association between diabetes and long-COVID-19–A systematic review. Diabetes Res. Clin. Pract. 195, 110202. doi:10.1016/j.diabres.2022.110202
Harich, B., Van Der Voet, M., Klein, M., Čížek, P., Fenckova, M., Schenck, A., et al. (2020). From rare copy number variants to biological processes in ADHD. Am. J. Psychiatry 177, 855–866. doi:10.1176/appi.ajp.2020.19090923
Harit, R., De, S., Singh, P. K., Kashyap, D., Kumar, M., Sahu, D., et al. (2024). Association of the C allele of rs479200 in the EGLN1 gene with COVID-19 severity in Indian population: a novel finding. Hum. Genomics 18, 7. doi:10.1186/s40246-024-00572-1
Hendrickx, J. O., Van Gastel, J., Leysen, H., Santos-Otte, P., Premont, R. T., Martin, B., et al. (2018). GRK5 – a functional Bridge between cardiovascular and neurodegenerative disorders. Front. Pharmacol. 9, 1484. doi:10.3389/fphar.2018.01484
Heneka, M. T., Carson, M. J., El Khoury, J., Landreth, G. E., Brosseron, F., Feinstein, D. L., et al. (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurology 14, 388–405. doi:10.1016/s1474-4422(15)70016-5
Herman, D. S., Lam, L., Taylor, M. R., Wang, L., Teekakirikul, P., Christodoulou, D., et al. (2012). Truncations of titin causing dilated cardiomyopathy. N. Engl. J. Med. 366, 619–628. doi:10.1056/NEJMoa1110186
Herrmann, D. N., Horvath, R., Sowden, J. E., Gonzalez, M., Sanchez-Mejias, A., Guan, Z., et al. (2014). Synaptotagmin 2 mutations cause an autosomal-dominant form of Lambert-Eaton myasthenic syndrome and nonprogressive motor neuropathy. Am. J. Hum. Genet. 95, 332–339. doi:10.1016/j.ajhg.2014.08.007
Hinton, R. B., Michelfelder, E. C., Marino, B. S., Bove, K. E., and Ware, S. M. (2010). A Fetus with hypertrophic cardiomyopathy, restrictive, and single-ventricle physiology, and a β-Myosin heavy chain mutation. J. Pediatrics 157, 164–166. doi:10.1016/j.jpeds.2010.02.044
Hu, Y., Lao, L., Mao, J., Jin, W., Luo, H., Charpentier, T., et al. (2017). Armc5 deletion causes developmental defects and compromises T-cell immune responses. Nat. Commun. 8, 13834. doi:10.1038/ncomms13834
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 220–232. doi:10.1016/s0140-6736(20)32656-8
Hubmacher, D., Schneider, M., Berardinelli, S. J., Takeuchi, H., Willard, B., Reinhardt, D. P., et al. (2017). Unusual life cycle and impact on microfibril assembly of ADAMTS17, a secreted metalloprotease mutated in genetic eye disease. Sci. Rep. 7, 41871. doi:10.1038/srep41871
Huynh, M. T., Landais, E., Agathe, J. S., Panchout, A., Caroline, V. B., and Bruel, H. (2023). Novel homozygous GLDC variant causing late-onset glycine encephalopathy: a case report and updated review of the literature. Mol. Genet. Metab. Rep. 34, 100959. doi:10.1016/j.ymgmr.2023.100959
Iino, S., Kobayashi, S., and Maekawa, S. (1999). Immunohistochemical localization of a novel acidic calmodulin-binding protein, NAP-22, in the rat brain. Neuroscience 91, 1435–1444. doi:10.1016/s0306-4522(98)00701-5
Janssens, B., Mohapatra, B., Vatta, M., Goossens, S., Vanpoucke, G., Kools, P., et al. (2003). Assessment of the CTNNA3 gene encoding human αT-catenin regarding its involvement in dilated cardiomyopathy. Hum. Genetics 112, 227–236. doi:10.1007/s00439-002-0857-5
Jena, D., Ghosh, A., Jha, A., Prasad, P., and Raghav, S. K. (2024). Impact of vaccination on SARS-CoV-2 evolution and immune escape variants. Vaccine 42, 126153. doi:10.1016/j.vaccine.2024.07.054
Jia, Y., Wang, X., Chen, Y., Qiu, W., Ge, W., and Ma, C. (2021). Proteomic and transcriptomic analyses reveal pathological changes in the entorhinal cortex Region that correlate well with dysregulation of ion transport in patients with Alzheimer's Disease. Mol. Neurobiol. 58, 4007–4027. doi:10.1007/s12035-021-02356-3
Jiang, M., Yang, L., Wu, J., Xiong, F., and Li, J. (2021). A de novo heterozygous variant in KAT6A is associated with a newly named neurodevelopmental disorder Arboleda-Tham syndrome-a case report. Transl. Pediatr. 10, 1748–1754. doi:10.21037/tp-21-206
Jin, J.-K., Blackwood, E. A., Azizi, K., Thuerauf, D. J., Fahem, A. G., Hofmann, C., et al. (2017). ATF6 decreases myocardial Ischemia/Reperfusion damage and links ER stress and oxidative stress signaling pathways in the heart. Circulation Res. 120, 862–875. doi:10.1161/CIRCRESAHA.116.310266
Jin, S. C., Lewis, S. A., Bakhtiari, S., Zeng, X., Sierant, M. C., Shetty, S., et al. (2020). Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nat. Genet. 52, 1046–1056. doi:10.1038/s41588-020-0695-1
Kalaivani, M. K., and Dinakar, S. (2022). Association between D-Dimer levels and post-acute sequelae of Sars-Cov-2 in patients from A tertiary care Center. Biomarkers Med. 16, 833–838. doi:10.2217/bmm-2022-0050
Kanai, M., Andrews, S. J., Cordioli, M., Stevens, C., Neale, B. M., Daly, M., et al. (2023). A second update on mapping the human genetic architecture of COVID-19. Nature 621, E7–E26. doi:10.1038/s41586-023-06355-3
Kant, S., Holthöfer, B., Magin, T. M., Krusche, C. A., and Leube, R. E. (2015). Desmoglein 2–Dependent arrhythmogenic cardiomyopathy is caused by a loss of adhesive function. Circ. Cardiovasc. Genet. 8, 553–563. doi:10.1161/circgenetics.114.000974
Karyakarte, R. P., Das, R., Rajmane, M. V., Dudhate, S., Agarasen, J., Pillai, P., et al. (2023). The burden and characteristics of Post-COVID-19 conditions among laboratory-confirmed Delta and Omicron COVID-19 cases: a preliminary Study from Maharashtra, India. Cureus 15, e44888. doi:10.7759/cureus.44888
Kaur Sardarni, U., Ambikan, A. T., Acharya, A., Johnson, S. D., Avedissian, S. N., Végvári, Á., et al. (2025). SARS-CoV-2 variants mediated tissue-specific metabolic reprogramming determines the disease pathophysiology in a hamster model. Brain Behav. Immun. 123, 914–927. doi:10.1016/j.bbi.2024.10.032
Kconsortium, G. (2019). The GenomeAsia 100K Project enables genetic discoveries across Asia. Nature 576, 106–111. doi:10.1038/s41586-019-1793-z
Kemp, E. H., Gawkrodger, D. J., Watson, P. F., and Weetman, A. P. (1998). Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA). Clin. Exp. Immunol. 114, 333–338. doi:10.1046/j.1365-2249.1998.00746.x
Kerdoncuff, E., Skov, L., Patterson, N., Zhao, W., Lueng, Y. Y., Schellenberg, G. D., et al. (2024). 50,000 years of Evolutionary History of India: insights from ∼2,700 Whole Genome Sequences. bioRxiv, 2024.02.15.580575. doi:10.1101/2024.02.15.580575
Khan, M. H., and Becker, R. C. (2024). Bridging the gap: strategies for recognizing and managing post-COVID conditions. Front. Med. 11, 1395420. doi:10.3389/fmed.2024.1395420
Kim, D., and Ackerman, S. L. (2011). The UNC5C netrin receptor regulates dorsal guidance of mouse hindbrain axons. J. Neurosci. 31, 2167–2179. doi:10.1523/JNEUROSCI.5254-10.2011
Kim, J., Park, D., Seo, N.-Y., Yoon, T.-H., Kim, G. H., Lee, S.-H., et al. (2022). LRRTM3 regulates activity-dependent synchronization of synapse properties in topographically connected hippocampal neural circuits. Neurosci. 119 (3), e2110196119. doi:10.1073/pnas.2110196119
Kleijer, K. T. E., Zuko, A., Shimoda, Y., Watanabe, K., and Burbach, J. P. H. (2015). Contactin-5 expression during development and wiring of the thalamocortical system. Neuroscience 310, 106–113. doi:10.1016/j.neuroscience.2015.09.039
Kloeckener-Gruissem, B., Vandekerckhove, K., Nürnberg, G., Neidhardt, J., Zeitz, C., Nürnberg, P., et al. (2008). Mutation of solute carrier SLC16A12 associates with a syndrome combining juvenile cataract with microcornea and renal glucosuria. Am. J. Hum. Genet. 82, 772–779. doi:10.1016/j.ajhg.2007.12.013
Kotschnew, K., Winkler, D., Reckmann, J., Mann, C., Schweigert, A., Tellkamp, G., et al. (2024). The double deficiency of the SNARE proteins vti1a and vti1b affects neurite outgrowth and signaling in N1E-115 neuroblastoma cells. Eur. J. Cell Biol. 103, 151461. doi:10.1016/j.ejcb.2024.151461
Kousathanas, A., Pairo-Castineira, E., Rawlik, K., Stuckey, A., Odhams, C. A., Walker, S., et al. (2022). Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature 607, 97–103. doi:10.1038/s41586-022-04576-6
Kumar, L., Chowdhari, A., Sequeira, J. J., Mustak, M. S., Banerjee, M., and Thangaraj, K. (2023). Genetic affinities and adaptation of the South-West Coast populations of India. Genome Biol. Evol. 15, evad225. doi:10.1093/gbe/evad225
Kunkle, B. W., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019). Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genetics 51, 414–430. doi:10.1038/s41588-019-0358-2
Kunwar, A. J., Rickmann, M., Backofen, B., Browski, S. M., Rosenbusch, J., Schöning, S., et al. (2011). Lack of the endosomal SNAREs vti1a and vti1b led to significant impairments in neuronal development. Proc. Natl. Acad. Sci. 108, 2575–2580. doi:10.1073/pnas.1013891108
Lammi, V., Nakanishi, T., Jones, S. E., Andrews, S. J., Karjalainen, J., Cortés, B., et al. (2025). Genome-wide association study of long COVID. Nat. Genet. 57, 1402–1417. doi:10.1038/s41588-025-02100-w
Lara-Pezzi, E., Felkin, L. E., Birks, E. J., Sarathchandra, P., Panse, K. D., George, R., et al. (2008). Expression of follistatin-related genes is altered in heart failure. Endocrinology 149, 5822–5827. doi:10.1210/en.2008-0151
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., et al. (2001). PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunology 2, 261–268. doi:10.1038/85330
Lavtar, P., Rudolf, G., Maver, A., Hodžić, A., Starčević Čizmarević, N., Živković, M., et al. (2018). Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis. PLoS One 13, e0190601. doi:10.1371/journal.pone.0190601
Lehnart, S. E., Wehrens, X. H., Laitinen, P. I. J., Reiken, S. R., Deng, S.-X., Cheng, Z., et al. (2004). Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109, 3208–3214. doi:10.1161/01.CIR.0000132472.98675.EC
Lewinter, M. M., and Granzier, H. L. (2013). Titin is a major human disease gene. Circulation 127, 938–944. doi:10.1161/CIRCULATIONAHA.112.139717
Li, D., Wang, Y., Xu, N., Wei, Q., Wu, M., Li, X., et al. (2011). Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis. Arthritis Research and Therapy 13, 1–12. doi:10.1186/ar3241
Li, Y., Ke, Y., Xia, X., Wang, Y., Cheng, F., Liu, X., et al. (2021). Genome-wide association study of COVID-19 severity among the Chinese population. Cell Discov. 7, 76. doi:10.1038/s41421-021-00318-6
Liu, F., Liang, Z., Shi, J., Yin, D., El-Akkad, E., Grundke-Iqbal, I., et al. (2006). PKA modulates GSK-3β-and cdk5-catalyzed phosphorylation of tau in site-and kinase-specific manners. FEBS Letters 580, 6269–6274. doi:10.1016/j.febslet.2006.10.033
Liu, J., Gao, L., Ji, B., Geng, R., Chen, J., Tao, X., et al. (2021a). BCL7A as a novel prognostic biomarker for glioma patients. J. Transl. Med. 19, 335. doi:10.1186/s12967-021-03003-0
Liu, J., Song, X., Kuang, F., Zhang, Q., Xie, Y., Kang, R., et al. (2021b). NUPR1 is a critical repressor of ferroptosis. Nat. Commun. 12, 647. doi:10.1038/s41467-021-20904-2
Logue, M. W., Schu, M., Vardarajan, B. N., Farrell, J., Bennett, D. A., Buxbaum, J. D., et al. (2014). Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans. Alzheimer's and Dementia 10, 609–618. doi:10.1016/j.jalz.2014.06.010
Love, M. I., Huber, W., and Anders, S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. doi:10.1186/s13059-014-0550-8
Maatz, H., Jens, M., Liss, M., Schafer, S., Heinig, M., Kirchner, M., et al. (2014). RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing. J. Clin. Invest 124, 3419–3430. doi:10.1172/JCI74523
Maekawa, S., Sato, C., Kitajima, K., Funatsu, N., Kumanogoh, H., and Sokawa, Y. (1999). Cholesterol-dependent localization of NAP-22 on a neuronal membrane microdomain (raft). J. Biol. Chem. 274, 21369–21374. doi:10.1074/jbc.274.30.21369
Malkova, A., Kudryavtsev, I., Starshinova, A., Kudlay, D., Zinchenko, Y., Glushkova, A., et al. (2021). Post COVID-19 syndrome in patients with Asymptomatic/Mild form. Pathogens 10, 1408. doi:10.3390/pathogens10111408
Mastana, S. S. (2014). Unity in diversity: an overview of the genomic anthropology of India. Ann. Hum. Biol. 41, 287–299. doi:10.3109/03014460.2014.922615
Mattorre, B., Tedeschi, V., Paldino, G., Fiorillo, M. T., Paladini, F., and Sorrentino, R. (2022). The emerging multifunctional roles of ERAP1, ERAP2 and IRAP between antigen processing and renin-angiotensin system modulation. Front. Immunol. 13, 1002375. doi:10.3389/fimmu.2022.1002375
Mayer, B., Funke, I., Seed, B., Riethmüller, G., and Weiss, E. (1990). Expression of the CD6 T lymphocyte differentiation antigen in normal human brain. J. Neuroimmunol. 29, 193–202. doi:10.1016/0165-5728(90)90162-g
Miller, J. A., Woltjer, R. L., Goodenbour, J. M., Horvath, S., and Geschwind, D. H. (2013). Genes and pathways underlying regional and cell type changes in Alzheimer's disease. Genome Medicine 5, 1–17. doi:10.1186/gm452
Miller, M. G., Terebuh, P., Kaelber, D. C., Xu, R., and Davis, P. B. (2024). SARS-CoV-2 Infection and New-Onset Type 2 diabetes among Pediatric Patients, 2020 to 2022. JAMA Netw. Open 7, e2439444. doi:10.1001/jamanetworkopen.2024.39444
Mina, Y., Enose-Akahata, Y., Hammoud, D. A., Videckis, A. J., Narpala, S. R., O'connell, S. E., et al. (2023). Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection. Neurology Neuroimmunol. and Neuroinflammation 10, e200097. doi:10.1212/NXI.0000000000200097
Misra, G., Manzoor, A., Chopra, M., Upadhyay, A., Katiyar, A., Bhushan, B., et al. (2023). Genomic epidemiology of SARS-CoV-2 from Uttar Pradesh, India. Sci. Rep. 13, 14847. doi:10.1038/s41598-023-42065-6
Mohandas, S., Yadav, P. D., Shete, A., Nyayanit, D., Sapkal, G., Lole, K., et al. (2021). SARS-CoV-2 Delta variant pathogenesis and host response in Syrian hamsters. Viruses 13, 1773. doi:10.3390/v13091773
Morales, J., Al-Sharif, L., Khalil, D. S., Shinwari, J. M., Bavi, P., Al-Mahrouqi, R. A., et al. (2009). Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am. J. Hum. Genet. 85, 558–568. doi:10.1016/j.ajhg.2009.09.011
Mousa, M., Vurivi, H., Kannout, H., Uddin, M., Alkaabi, N., Mahboub, B., et al. (2021). Genome-wide association study of hospitalized COVID-19 patients in the United Arab Emirates. EBioMedicine 74, 103695. doi:10.1016/j.ebiom.2021.103695
Musunuri, S., Wetterhall, M., Ingelsson, M., Lannfelt, L., Artemenko, K., Bergquist, J., et al. (2014). Quantification of the brain proteome in Alzheimer’s disease using multiplexed mass spectrometry. J. Proteome Research 13, 2056–2068. doi:10.1021/pr401202d
Narasimhan, V. M., Patterson, N., Moorjani, P., Rohland, N., Bernardos, R., Mallick, S., et al. (2019). The formation of human populations in south and Central Asia. Science 365, eaat7487. doi:10.1126/science.aat7487
Nguyen, N. T., Chinn, J., De Ferrante, M., Kirby, K. A., Hohmann, S. F., and Amin, A. (2021). Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS One 16, e0254066. doi:10.1371/journal.pone.0254066
Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., et al. (2021). Mapping the human genetic architecture of COVID-19. Nature 600, 472–477. doi:10.1038/s41586-021-03767-x
Oscanoa, J., Sivapalan, L., Gadaleta, E., Dayem ullah, A. Z., Lemoine, N. r., and Chelala, C. (2020). SNPnexus: a web server for functional annotation of human genome sequence variation (2020 update). Nucleic Acids Res. 48, W185–W192. doi:10.1093/nar/gkaa420
Pairo-Castineira, E., Clohisey, S., Klaric, L., Bretherick, A. D., Rawlik, K., Pasko, D., et al. (2021). Genetic mechanisms of critical illness in COVID-19. Nature 591, 92–98. doi:10.1038/s41586-020-03065-y
Pandey, K., Acharya, A., Mohan, M., Ng, C. L., Reid, S. P., and Byrareddy, S. N. (2021). Animal models for SARS-CoV-2 research: a comprehensive literature review. Transbound. Emerg. Dis. 68, 1868–1885. doi:10.1111/tbed.13907
Pandey, R. K., Srivastava, A., Mishra, R. K., Singh, P. P., and Chaubey, G. (2024). Novel genetic association of the Furin gene polymorphism rs1981458 with COVID-19 severity among Indian populations. Sci. Rep. 14, 7822. doi:10.1038/s41598-024-54607-7
Piggott, L. A., Bauman, A. L., Scott, J. D., and Dessauer, C. W. (2008). The A-kinase anchoring protein Yotiao binds and regulates adenylyl cyclase in brain. Proc. Natl. Acad. Sci. 105, 13835–13840. doi:10.1073/pnas.0712100105
Plott, C., Harb, T., Arvanitis, M., Gerstenblith, G., Blumenthal, R., and Leucker, T. (2024). Neurocardiac axis physiology and clinical applications. Int. J. Cardiol. Heart Vasc. 54, 101488. doi:10.1016/j.ijcha.2024.101488
Poli, A. N. R., Tietjen, I., Nandwana, N. K., Cassel, J., Messick, T. E., Register, E. T., et al. (2024). Design of novel and highly selective SARS-CoV-2 main protease inhibitors. Antimicrob. Agents Chemother. 68, e0056224. doi:10.1128/aac.00562-24
Poliak, S., Morales, D., Croteau, L. P., Krawchuk, D., Palmesino, E., Morton, S., et al. (2015). Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons. Elife 4, e10841. doi:10.7554/eLife.10841
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575. doi:10.1086/519795
Rajaiah, R., Pandey, K., Acharya, A., Ambikan, A., Kumar, N., Guda, R., et al. (2024). Differential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters. iScience 27, 110501. doi:10.1016/j.isci.2024.110501
Ravi, V., Shamim, U., Khan, M. A., Swaminathan, A., Mishra, P., Singh, R., et al. (2023). Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages. Front. Med. (Lausanne) 10, 1294699. doi:10.3389/fmed.2023.1294699
Reich, D., Thangaraj, K., Patterson, N., Price, A. L., and Singh, L. (2009). Reconstructing Indian population history. Nature 461, 489–494. doi:10.1038/nature08365
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., Mcginn, T., Davidson, K. W., et al. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama 323, 2052–2059. doi:10.1001/jama.2020.6775
Richardson, T. G., Wang, Q., Sanderson, E., Mahajan, A., Mccarthy, M. I., Frayling, T. M., et al. (2021). Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives. Lancet Healthy Longev. 2, e317–e326. doi:10.1016/S2666-7568(21)00086-6
Ridge, P. G., Hoyt, K. B., Boehme, K., Mukherjee, S., Crane, P. K., Haines, J. L., et al. (2016). Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol. Aging 41, 200.e213–200.e220. doi:10.1016/j.neurobiolaging.2016.02.024
Ritter, A., Leonard, J., Gray, C., Izumi, K., Levinson, K., Nair, D. R., et al. (2022). Variants cause complex congenital heart disease. Am. J. Med. Genet. Part A 188, 2772–2776. doi:10.1002/ajmg.a.62766
Rothan, H. A., and Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 109, 102433. doi:10.1016/j.jaut.2020.102433
Samanta, A., Ahamed, A., Alam, S. S. M., Ali, S., Shahnawaz Khan, M., Al-Amri, A. M., et al. (2023). Non-synonymous single nucleotide polymorphisms in human ACE2 gene May affect the infectivity of SARS-CoV-2 omicron subvariants. Curr. Pharm. Des. 29, 2891–2901. doi:10.2174/0113816128275739231106055502
Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., et al. (2011). Multiple recurrent de novo CNVs, including duplications of the 7q11. 23 Williams syndrome region, are strongly associated with autism. Neuron 70, 863–885. doi:10.1016/j.neuron.2011.05.002
Sassoè-Pognetto, M., Frola, E., Pregno, G., Briatore, F., and Patrizi, A. (2011). Understanding the molecular diversity of GABAergic synapses. Front. Cell Neurosci. 5, 4. doi:10.3389/fncel.2011.00004
Selvavinayagam, S. T., Sankar, S., Yong, Y. K., Murugesan, A., Suvaithenamudhan, S., Hemashree, K., et al. (2024). Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - clinical characteristics and novel mutations. Sci. Rep. 14, 17476. doi:10.1038/s41598-024-68678-z
Shelton, J. F., Shastri, A. J., Ye, C., Weldon, C. H., Filshtein-Sonmez, T., Coker, D., et al. (2021). Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat. Genet. 53, 801–808. doi:10.1038/s41588-021-00854-7
Shenoy, P. U., Udupa, H., Ks, J., Babu, S., K, N., Jain, N., et al. (2023). The impact of COVID-19 on pulmonary, neurological, and cardiac outcomes: evidence from a Mendelian randomization study. Front. Public Health 11, 1303183. doi:10.3389/fpubh.2023.1303183
Shi, Y., Liu, W., Yang, Y., Ci, Y., and Shi, L. (2023). Exploration of the shared molecular mechanisms between COVID-19 and neurodegenerative diseases through bioinformatic analysis. Int. J. Mol. Sci. 24, 4839. doi:10.3390/ijms24054839
Škrlec, I., Milić, J., and Steiner, R. (2020). The impact of the circadian genes CLOCK and ARNTL on myocardial infarction. J. Clin. Med. 9, 484. doi:10.3390/jcm9020484
Smith, E. A., and Fuchs, E. (1998). Defining the interactions between intermediate filaments and desmosomes. J. Cell Biology 141, 1229–1241. doi:10.1083/jcb.141.5.1229
Sousa, I., Clark, T. G., Holt, R., Pagnamenta, A. T., Mulder, E. J., Minderaa, R. B., et al. (2010). Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry. Mol. Autism 1, 7. doi:10.1186/2040-2392-1-7
Spudich, S., and Nath, A. (2022). Nervous system consequences of COVID-19. Science 375, 267–269. doi:10.1126/science.abm2052
St. George-Hyslop, F., Kivisild, T., and Livesey, F. J. (2022). The role of contactin-associated protein-like 2 in neurodevelopmental disease and human cerebral cortex evolution. Front. Mol. Neurosci. 15, 1017144. doi:10.3389/fnmol.2022.1017144
Statistics (2022). U.S. census bureau, household pulse survey, 2022–2024. Long COVID. Generated interactively. Available online at: https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (Accessed December 6, 2024).
Steiner, S., Kratzel, A., Barut, G. T., Lang, R. M., Aguiar Moreira, E., Thomann, L., et al. (2024). SARS-CoV-2 biology and host interactions. Nat. Rev. Microbiol. 22, 206–225. doi:10.1038/s41579-023-01003-z
Stephenson, T., Pinto Pereira, S. M., Nugawela, M. D., Dalrymple, E., Harnden, A., Whittaker, E., et al. (2024). A 24-month National Cohort Study examining long-term effects of COVID-19 in children and young people. Commun. Med. (Lond) 4, 255. doi:10.1038/s43856-024-00657-x
Stolz, J. R., Foote, K. M., Veenstra-Knol, H. E., Pfundt, R., Ten Broeke, S. W., De Leeuw, N., et al. (2021). Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders. Am. J. Hum. Genet. 108, 1692–1709. doi:10.1016/j.ajhg.2021.09.018
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., et al. (2024). Cell–cell communication: new insights and clinical implications. Signal Transduct. Target. Ther. 9, 196. doi:10.1038/s41392-024-01888-z
Subramanian, A., Nirantharakumar, K., Hughes, S., Myles, P., Williams, T., Gokhale, K. M., et al. (2022). Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 28, 1706–1714. doi:10.1038/s41591-022-01909-w
Sun, Y., Zhu, J., Zhou, D., Canchi, S., Wu, C., Cox, N. J., et al. (2021). A transcriptome-wide association study of Alzheimer's disease using prediction models of relevant tissues identifies novel candidate susceptibility genes. Genome Med. 13, 141. doi:10.1186/s13073-021-00959-y
Thorkelsson, A., and Chin, M. T. (2024). Role of the Alpha-B-Crystallin protein in cardiomyopathic disease. Int. J. Mol. Sci. 25, 2826. doi:10.3390/ijms25052826
Thyagaraj, V., Rao, A., Kulkarni, A., Shankar, T., R, N., Unnikrishnan, H., et al. (2022). Clinical and laboratory profile of patients visiting the Post-COVID-19 Clinic at a tertiary care Hospital: a cross-sectional Study. Cureus 14, e22888. doi:10.7759/cureus.22888
Țiburcă, L., Zaha, D. C., Jurca, M. C., Severin, E., Jurca, A., and Jurca, A. D. (2024). The role of aminopeptidase ERAP1 in human Pathology-A review. Curr. Issues Mol. Biol. 46, 1651–1667. doi:10.3390/cimb46030107
Triambak, S., Mahapatra, D. P., Barik, N., and Chutjian, A. (2023). Plausible explanation for the third COVID-19 wave in India and its implications. Infect. Dis. Model 8, 183–191. doi:10.1016/j.idm.2023.01.001
Tse, G., Lee, S., Zhou, J., Liu, T., Wong, I. C. K., Mak, C., et al. (2021). Territory-wide Chinese cohort of long QT syndrome: random survival forest and Cox analyses. Front. Cardiovasc. Med. 8, 608592. doi:10.3389/fcvm.2021.608592
Tucić, M., Stamenković, V., and Andjus, P. (2021). The extracellular matrix glycoprotein Tenascin C and adult neurogenesis. Front. Cell Dev. Biol. 9, 674199. doi:10.3389/fcell.2021.674199
Ucuncu, E., Rajamani, K., Wilson, M. S. C., Medina-Cano, D., Altin, N., David, P., et al. (2020). MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in pontocerebellar hypoplasia. Nat. Commun. 11, 6087. doi:10.1038/s41467-020-19919-y
Um, J. W., Choi, T.-Y., Kang, H., Cho, Y. S., Choii, G., Uvarov, P., et al. (2016). LRRTM3 regulates excitatory synapse development through alternative splicing and neurexin binding. Cell Rep. 14, 808–822. doi:10.1016/j.celrep.2015.12.081
Upadhyai, P., Suresh, G., Parit, R., and Das, R. (2021). Genomic and ancestral variation underlies the severity of COVID-19 clinical manifestation in individuals of European descent. Life (Basel) 11, 921. doi:10.3390/life11090921
Upadhyai, P., Shenoy, P. U., Banjan, B., Albeshr, M. F., Mahboob, S., Manzoor, I., et al. (2022). Exome-Wide Association Study reveals host genetic variants likely associated with the severity of COVID-19 in patients of European Ancestry. Life (Basel) 12, 1300. doi:10.3390/life12091300
Urreizti, R., Lopez-Martin, E., Martinez-Monseny, A., Pujadas, M., Castilla-Vallmanya, L., Pérez-Jurado, L. A., et al. (2020). Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum. Orphanet J. Rare Dis. 15, 44. doi:10.1186/s13023-020-1317-9
Van Noort, J. M., Van Sechel, A. C., Bajramovic, J. J., Ouagmiri, M. E., Polman, C. H., Lassmann, H., et al. (1995). The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis. Nature 375, 798–801. doi:10.1038/375798a0
Vanelzakker, M. B., Bues, H. F., Brusaferri, L., Kim, M., Saadi, D., Ratai, E.-M., et al. (2024). Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures. Brain, Behav. Immun. 119, 713–723. doi:10.1016/j.bbi.2024.04.015
Wadhwa, K., Malik, S., Balaji, S., Thiruvengadam, R., Bashyam, M. D., Bhattacharya, P. K., et al. (2024). Correlation of severity and clinical outcomes of COVID-19 with virus variants: a prospective, multicentre hospital network study. Indian J. Med. Res. 159, 91–101. doi:10.4103/ijmr.ijmr_1041_23
Wang, Y., Shen, J., Arenzana, N., Tirasophon, W., Kaufman, R. J., and Prywes, R. (2000). Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J. Biol. Chem. 275, 27013–27020. doi:10.1016/s0021-9258(19)61473-0
Wang, Y., Li, D., Xu, N., Tao, W., Zhu, R., Sun, R., et al. (2011). Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis. Arthritis Research and Therapy 13, 1–11. doi:10.1186/ar3522
Wingo, T. S., Cutler, D. J., Wingo, A. P., Le, N.-A., Rabinovici, G. D., Miller, B. L., et al. (2019). Association of early-onset Alzheimer disease with elevated low-density lipoprotein cholesterol levels and rare genetic coding variants of APOB. JAMA Neurol. 76, 809–817. doi:10.1001/jamaneurol.2019.0648
Woo, M. S., Malsy, J., Pöttgen, J., Seddiq Zai, S., Ufer, F., Hadjilaou, A., et al. (2020). Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Communications 2, fcaa205. doi:10.1093/braincomms/fcaa205
Wu, Q.-W., and Kapfhammer, J. P. (2021). Modulation of increased mGluR1 signaling by RGS8 protects purkinje cells from dendritic reduction and could be a common mechanism in diverse forms of spinocerebellar ataxia. Front. Cell Dev. Biol. 8, 569889. doi:10.3389/fcell.2020.569889
Xie, K., Liu, Y., Hao, W., Walter, S., Penke, B., Hartmann, T., et al. (2013). Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice. Neurobiol. Aging 34, 2389–2398. doi:10.1016/j.neurobiolaging.2013.04.013
Xie, Y., Liu, Z., Liu, K., Qi, H., Peng, W., Cao, H., et al. (2021). Candidate gene polymorphisms influence the susceptibility to salt sensitivity of blood pressure in a Han Chinese population: risk factors as mediators. Front. Genet. 12, 675230. doi:10.3389/fgene.2021.675230
Yi, J. M., Dhir, M., Guzzetta, A. A., Iacobuzio-Donahue, C. A., Heo, K., Yang, K. M., et al. (2012). DNA methylation biomarker candidates for early detection of colon cancer. Tumor Biol. 33, 363–372. doi:10.1007/s13277-011-0302-2
Yotti, R., Seidman, C. E., and Seidman, J. G. (2019). Advances in the genetic basis and pathogenesis of sarcomere cardiomyopathies. Annu. Review Genomics Human Genetics 20, 129–153. doi:10.1146/annurev-genom-083118-015306
Yu, Q., Fan, M., Lin, C. J., Lui, D. T. W., Tan, K. C. B., Yiu, K. H., et al. (2024). Risk factors for long-term cardiovascular post-acute sequelae of COVID-19 infection: a nested case-control study in Hong Kong. Npj Cardiovasc. Health 1, 10. doi:10.1038/s44325-024-00011-z
Zheng, Z., Liu, S., Wang, C., Wang, C., Tang, D., Shi, Y., et al. (2019). Association of genetic polymorphisms in CASP7 with risk of ischaemic stroke. Sci. Rep. 9, 18627. doi:10.1038/s41598-019-55201-y
Glossary
ABCC2 ATP-binding cassette subfamily C member 2
ADAMTS17 A disintegrin and metalloproteinase with thrombospondin motifs 17
ADGRL2 Adhesion G protein-coupled receptor L2
ADK Adenosine kinase
ALDH2 Aldehyde dehydrogenase 2
ANO1 Anoctamin-1 (Ca2+-activated chloride channel)
APP Amyloid precursor protein
ARHGAP32 Rho GTPase-activating protein 32
BASP1 Brain abundant membrane-attached signal protein 1
CACNA1A Calcium voltage-gated channel subunit α1 A
CACNA1B Calcium voltage-gated channel subunit α1 B
CACNA1C Calcium voltage-gated channel subunit α1 C
CACNA2D3 Calcium voltage-gated channel auxiliary subunit α2δ3
CAMK2D Calcium/calmodulin-dependent protein kinase II delta
CCHCR1 Coiled-coil alpha-helical rod protein 1
CHRM3 Cholinergic receptor muscarinic 3
CNTNAP2 Contactin-associated protein-like 2
CNTNAP5 Contactin-associated protein-like 5
COL5A2 Collagen type V alpha 2 chain
COL6A2 Collagen type VI alpha 2 chain
CSMD2 CUB and Sushi multiple domains 2
CTBP2 C-terminal binding protein 2
CTNNA3 Catenin alpha 3
CXADR Coxsackievirus and adenovirus receptor
DAB1 Disabled homolog 1
DCC Deleted in colorectal carcinoma (netrin receptor)
DLG2 Discs large MAGUK scaffold protein 2
DLGAP1 Discs large-associated protein 1
DSP Desmoplakin
DSG2 Desmoglein 2
DPP10 Dipeptidyl peptidase-like 10
ERBB3 Erb-b2 receptor tyrosine kinase 3
FBN1 Fibrillin 1
FLT1 Fms-related receptor tyrosine kinase 1 (VEGFR1)
FOXP1 Forkhead box P1
GATA3 GATA-binding protein 3
GNAO1 G protein subunit alpha O1
GRID1 Glutamate ionotropic receptor delta type subunit 1
GRIK3 Glutamate ionotropic receptor kainate type subunit 3
GRK5 G protein-coupled receptor kinase 5
GRM7 Glutamate metabotropic receptor 7
HSPB7 Heat shock protein family B member 7
HTR4 5-hydroxytryptamine receptor 4
HTR7 5-hydroxytryptamine receptor 7
IGF1 Insulin-like growth factor 1
IL-10RB Interleukin 10 receptor subunit beta
ITPR2 Inositol 1,4,5-trisphosphate receptor type 2
JAK1 Janus kinase 1
KANSL1 KAT8 regulatory NSL complex subunit 1
KCNQ1 Potassium voltage-gated channel subfamily Q member 1
LPA Lipoprotein(a)
LRRK2 Leucine-rich repeat kinase 2
MAP2 Microtubule-associated protein 2
MYBPC3 Myosin-binding protein C, cardiac type
MYH11 Myosin heavy chain 11
NLGN1 Neuroligin 1
NOS1 Nitric oxide synthase 1
NOS1AP Nitric oxide synthase 1 adaptor protein
NPAS2 Neuronal PAS domain protein 2
NRXN1 Neurexin 1
NUP133 Nucleoporin 133
PDE4B Phosphodiesterase 4B
PDGFD Platelet-derived growth factor D
PLPP3 Phospholipid phosphatase 3
PLSCR1 Phospholipid scramblase 1
PRKAA2 Protein kinase AMP-activated catalytic subunit alpha 2
PRKG1 Protein kinase, cGMP-dependent, type I
RBFOX1 RNA binding fox-1 homolog 1
RGS5 Regulator of G-protein signaling 5
RGS6 Regulator of G-protein signaling 6
RUNX3 Runt-related transcription factor 3
RYR2 Ryanodine receptor 2
SFTPD Surfactant protein D
SLC1A3 Solute carrier family 1 member 3
SLC6A20 Solute carrier family 6 member 20
SLC8A1 Solute carrier family 8 member 1
SLC2A9 Solute carrier family 2 member 9
TTN Titin
TRPM8 Transient receptor potential cation channel subfamily M member 8
UNC5C Uncoordinated-5 homolog C
VWF Von Willebrand factor
WWOX WW domain-containing oxidoreductase
ZMYM4 Zinc finger MYM-type containing 4
Keywords: post-acute sequelae of COVID-19, COVID-19 host-genetics, genome-wide association study, genetic epidemiology, multiomics
Citation: Shenoy PU, Udupa H, Ananthakrishnan AI, Sunil P, Sardarni UK, Kumar N, Acharya A, Byrareddy SN, Upadhyai P and Das R (2026) Genomic and ancestral variations linked to the development of post-acute sequelae of SARS-CoV-2 infection in Indian populations. Front. Genet. 16:1696764. doi: 10.3389/fgene.2025.1696764
Received: 04 September 2025; Accepted: 24 November 2025;
Published: 06 January 2026; Corrected: 30 January 2026.
Edited by:
Francesca Colombo, National Research Council (CNR), ItalyReviewed by:
Jeremy J. Yang, University of New Mexico, United StatesXiaoShan JI, Fudan University, China
Débora Dummer Meira, Federal University of Espirito Santo, Brazil
Giulia Maria Giacinti, Federal University of Espírito Santo, Vitória, Brazil, in collaboration with reviewer DM
Copyright © 2026 Shenoy, Udupa, Ananthakrishnan, Sunil, Sardarni, Kumar, Acharya, Byrareddy, Upadhyai and Das. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ranajit Das, ZGFzLnJhbmFqaXRAZ21haWwuY29t; Priyanka Upadhyai, UHJpeWFua2EudUBtYW5pcGFsLmVkdQ==; Siddappa N. Byrareddy, c2lkLmJ5cmFyZWRkeUB1bm1jLmVkdQ==